Doctors have developed an “artificial ovary” from human eggs and tissue so as to aid women to give birth after the treatment for cancer and different other therapies that can harm women’s fertility.
The group in Copenhagen demonstrated that a lab-made ovary could sustain life of human eggs for a considerable length of time at once, raising expectations that the approach would someday be able to aid women in starting families of their own after undergoing difficult procedures, for example, radiotherapy and chemotherapy.
The implanted ovaries are expected to help women suffering from the blood disorder, named thalassemia and even in multiple sclerosis. The treatment of such diseases requires extensive therapies which are seen to harm the fertility quotient in women. The discovery also seems helpful for women having early menopause.
Women who undergo cancer diagnosis and treatment would now be able to get their ovaries removed and frozen before they start the treatment. When they are declared cancer-free, the ovaries could be put back and they would work the same to get pregnant, naturally.
For most patients, the process is said to be safe, yet certain tumors, for example, ovarian or leukemia, can attack the ovarian tissue as well. This implies when preserved tissue is defrosted and returned, there is a change of getting relapsed by the tumor once again. Therefore, the option to freeze ovarian tissue is hardly offered to patients with high-risk.
Susanne Pors and others at the Rigshospitalet in Copenhagen accept artificial ovaries could be a more secure alternative. The doctors at that point seeded this platform with many human follicles, the small sacs that hold initial-stage eggs. Pors, on Monday, would be addressing and telling in a yearly meeting of the European Society of Human Reproduction and Embryology at Barcelona, about the method with which the team implanted the artificial ovary.